Technology
Health
Biotechnology
Applied Therapeutics
$9.549876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$9.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.64 (7.19%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell APLT and other stocks, options, ETFs, and crypto commission-free!
About APLT
Applied Therapeutics, Inc. Common Stock, also called Applied Therapeutics, is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. Read More The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
Employees
—
Headquarters
New York, New York
Founded
2016
Market Cap
162.68M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.60K
High Today
$9.75
Low Today
$8.75
Open Price
$8.97
Volume
6.74K
52 Week High
$11.20
52 Week Low
$7.95
Collections
Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Pharmaceutical
2019 IPO
APLT Earnings
-$0.72
-$0.64
-$0.56
-$0.48
Q2 2019
Estimated
—
Actual
-$0.60 per share